Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Summary 
Hans-Peter Hasler is a Swiss businessperson who founded Vicarius Pharma AG and who has been at the head of 7 different companies. Mr. Hasler is Non-Executive Chairman at Shield Therapeutics Plc, Chairman of Medical Imaging Analysis Center and Chairman for HBM Healthcare Investments AG.

He is also on the board of Minerva Neurosciences, Inc., Dr. Reddy's Laboratories SA, Vicarius Pharma AG (former Chief Executive Officer & Director) and Gain Therapeutics, Inc. and Principal at Hph Management GmbH.

In the past he was Managing Director at Wyeth-lederle Pharma GmbH, COO, EVP, Head-Global Neurology & International at Biogen, Inc. Chief Operating Officer of Biogen Idec, Inc. (North Carolina) and Executive Vice President-International at Biogen MA, Inc. (both are subsidiaries of Biogen, Inc.), Managing Director at Wyeth Pharma GmbH, Managing Director at Wyeth Pharmaceuticals AG, Chief Operating Officer at Elan Corp. Plc, Chief Marketing Officer of Wyeth Corp. and Chief Marketing Officer & Senior Vice President of Wyeth Pharmaceuticals LLC.

Mr. Hasler received an undergraduate degree from Schweizerisches Institut fŘr Betriebs÷konomie AG.


Current positions of Hans-Peter Hasler 
NameTitle Since
HBM Healthcare Investments AG
(Investment Management & Fund Operators)
Chairman 2009
Gain Therapeutics, Inc.
(Biotechnology & Medical Research)
Independent Director 2021
Shield Therapeutics plc
(Biotechnology & Medical Research)
Non-Executive Chairman 2020
Minerva Neurosciences, Inc.
(Biotechnology & Medical Research)
Independent Director 2017
Medical Imaging Analysis Center Chairman 2012
Dr. Reddy's Laboratories SA Director -
Vicarius Pharma AG Director 2020
Hph Management GmbH Principal -


Holdings of Hans-Peter Hasler 
NameEquities%Valuation
HBM Healthcare Investments AG (HBMN)
(Investment Management & Fund Operators)
12,8410.18%2,848,566 USD
Shield Therapeutics plc (STX)
(Biotechnology & Medical Research)
500,0000.19%44,615 USD
Minerva Neurosciences, Inc. (NERV)
(Biotechnology & Medical Research)
1,2500.023%3,313 USD


Hans-Peter Hasler: Personal Network 
Most Read News 
12/01Salesforce shares tumble after surprise exit of co-CEO Taylor
RE
11/23Berkshire Hathaway says Warren Buffett donates shares to family charities
RE
11/30Meta's Zuckerberg says some of Elon Musk's Twitter content approach 'might work'
RE
11/30Interpol confirms red notice for Angolan billionaire Isabel dos Santos
RE
11/30Juventus has no requirement of additional capital, says Exor's Elkann
RE
12/06The rise and fall of Wirecard
RE
11/29Ryanair's O'Leary says industry most optimistic in 25 years
RE
11/25Elon Musk says Twitter's ban on Trump after Capitol attack was 'grave mistake'
RE
11/28Leon Black accused in lawsuit of raping woman in Jeffrey Epstein's mansion
RE
12/02Russia is ready to provide increased gas supplies to Uzbekistan, Deputy PM Novak says
RE
More news


© 2022 People and Ownership :   
Hans-Peter Hasler : Connections